Trials / Completed
CompletedNCT00266578
A Study Comparing Swallowed Flovent and Placebo in Patients With Eosinophilic Disorders
Effect of Swallowed Fluticasone Propionate on Eosinophilic Esophagitis; A Prospective, Randomized, Placebo-Controlled Trial
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Marc Rothenberg · Academic / Other
- Sex
- All
- Age
- 3 Years – 30 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is assessing the efficacy of swallowed Flovent® vs. placebo for the treatment of eosinophilic esophagitis (EE).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fluticasone Propionate | Flovent vs. placebo daily for 3 months |
Timeline
- Start date
- 2002-10-01
- Primary completion
- 2006-11-01
- Completion
- 2012-10-01
- First posted
- 2005-12-19
- Last updated
- 2013-04-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00266578. Inclusion in this directory is not an endorsement.